Momentum Bioscience is focused on developing rapid tests for bloodstream infection in patients suspected of sepsis.
SepsiSTAT® is our direct-from-blood, rapid screening technology, providing actionable results for suspected sepsis patients.
SepsiSTAT® contains our three proprietary capabilities:
1. Sensitive and universal microbial capture
2. Universal detection of viable microorganisms
3. Organism profiling
Only by using Momentum’s proprietary universal pathogen capture, detection & identification capabilities can all patients suspected of sepsis expect actionable results for bloodstream infection in <3 hours. Not days.
This will have a significant impact on patient management, the management of antibiotics and help mitigate the problem of increasing antimicrobial resistance.
Momentum is seeking partners for joint commercialisation.
Momentum was founded in 2008 to develop rapid tests for critically-important clinical specimens within the hospital microbiology laboratory. The Company is backed by its founders, business angels and venture capital. Momentum is headquartered near Cardiff and has a R&D facility near Oxford in the UK.
SepsiSTAT® is our direct-from-blood, rapid screening technology, providing actionable results for suspected sepsis patients.
SepsiSTAT® contains our three proprietary capabilities:
1. Sensitive and universal microbial capture
2. Universal detection of viable microorganisms
3. Organism profiling
Only by using Momentum’s proprietary universal pathogen capture, detection & identification capabilities can all patients suspected of sepsis expect actionable results for bloodstream infection in <3 hours. Not days.
This will have a significant impact on patient management, the management of antibiotics and help mitigate the problem of increasing antimicrobial resistance.
Momentum is seeking partners for joint commercialisation.
Momentum was founded in 2008 to develop rapid tests for critically-important clinical specimens within the hospital microbiology laboratory. The Company is backed by its founders, business angels and venture capital. Momentum is headquartered near Cardiff and has a R&D facility near Oxford in the UK.
Location: United Kingdom, Wales, Cardiff
Founded date: 2008
Investors 4
| Date | Name | Website |
| - | Esperante | esperante.... |
| - | Oxford Inv... | oxfordinve... |
| 22.01.2025 | Cambridge ... | cambridgea... |
| - | Perivoli I... | perivoliin... |
Mentions in press and media 3
| Date | Title | Description |
| 04.07.2024 | Gradientech and Momentum Bioscience in continued collaboration | Gradientech and Momentum Bioscience in continued collaboration Thu, Jul 04, 2024 09:05 CET Report this content The diagnostics company Gradientech today announces the continued collaboration with Oxford-based Momentum Bioscience Ltd in the ... |
| 04.01.2022 | Vanta Bioscience Limited Receives Order of INR 11.8 Million from Coromandel International Limited | Vanta Bioscience Limited has received an order of INR 11.8 million from Coromandel International Limited, India for carrying out various preclinical studies/toxicity studies on animals, agrochem studies and other studies. This prestigious o... |
| 26.09.2011 | Momentum Bioscience Funding £230K Round | Momentum Bioscience Limited, a Reading, UK-based Medtech company, has closed a £230k round. This includes £180k from LBA investors, which made the investment through the LBA EIS RoundTable Syndicate Fund 2011, and significant investment fro... |